Bone Marrow Transplantation and Immune Deficiency

Publications

Addison, J; Razzaghi, H; Bailey, C; Dickinson, K; Corathers, SD; Hartley, DM; Utidjian, L; Carle, AC; Rhodes, ET; Alonso, GT; et al. Testing an Automated Approach to Identify Variation in Outcomes among Children with Type 1 Diabetes across Multiple Sites. Pediatric Quality and Safety. 2022; 7.

Arnold, DE; Chellapandian, D; Parikh, S; Mallhi, K; Marsh, RA; Heimall, JR; Grossman, D; Chitty-Lopez, M; Murguia-Favela, L; Gennery, AR; et al. Granulocyte Transfusions in Patients with Chronic Granulomatous Disease Undergoing Hematopoietic Cell Transplantation or Gene Therapy. Journal of Clinical Immunology. 2022; 42:1026-1035.

Arnold, DE; Nofal, R; Wakefield, C; Lehmberg, K; Wustrau, K; Albert, MH; Morris, EC; Heimall, JR; Bunin, NJ; Kumar, A; et al. Reduced-Intensity/Reduced-Toxicity Conditioning Approaches Are Tolerated in XIAP Deficiency but Patients Fare Poorly with Acute GVHD. Journal of Clinical Immunology. 2022; 42:36-45.

Auletta, JJ; Sandmaier, BM; Jensen, E; Majhail, NS; Knutson, J; Nemecek, E; Ajayi-Hackworth, F; Davies, SM; Additional Contributing ACCESS Workshop Team Membe, . The ASTCT-NMDP ACCESS Initiative: A Collaboration to Address and Sustain Equal Outcomes for All Across the Hematopoietic Cell Transplantation and Cellular Therapy Ecosystem. Transplantation and cellular therapy. 2022.

Benoit, SW; Khandelwal, P; Grimley, MS. A case of treatment-resistant membranous nephropathy associated with graft versus host disease successfully treated with daratumumab. Pediatric Transplantation. 2022; 26.

Bleesing, J. Gain-of-function defects in toll-like receptor 8 shed light on the interface between immune system and bone marrow failure disorders. Frontiers in Immunology. 2022; 13.

Cancio, M; Hebert, K; Kim, S; Aljurf, M; Olson, T; Anderson, E; Burroughs, L; Vatsayan, A; Myers, K; Hashem, H; et al. Outcomes in Hematopoietic Stem Cell Transplantation for Congenital Amegakaryocytic Thrombocytopenia. Transplantation and cellular therapy. 2022; 28:101.e1-101.e6.

Chandra, S; Mizuno, K; Zhao, J; Davies, SM; Marsh, RA; Fukuda, T; Setchell, KD R; Vinks, AA; Mehta, PA. Test-dose pharmacokinetics guided melphalan dose adjustment in reduced intensity conditioning allogeneic transplant for non-malignant disorders. British Journal of Clinical Pharmacology. 2022; 88:115-127.

Chiang, SC C; Owsley, E; Panchal, N; Chaturvedi, V; Terrell, CE; Jordan, MB; Mehta, PA; Davies, SM; Akeno, N; Booth, C; et al. Quercetin ameliorates XIAP deficiency-associated hyperinflammation. Blood. 2022; 140:706-715.

Chihanga, T; Vicente-Muñoz, S; Ruiz-Torres, S; Pal, B; Sertorio, M; Andreassen, PR; Khoury, R; Mehta, P; Davies, SM; Lane, AN; et al. Head and Neck Cancer Susceptibility and Metabolism in Fanconi Anemia. Cancers. 2022; 14.

Cuvelier, GD E; Logan, BR; Prockop, SE; Buckley, RH; Kuo, CY; Griffith, LM; Liu, X; Yip, A; Hershfield, MS; Ayoub, PG; et al. Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTC. Blood. 2022; 140:685-705.

Davila Saldana, BJ; John, T; Bonifant, C; Buchbinder, D; Chandra, S; Chandrakasan, S; Chang, W; Chen, L; Elfassy, HL; Geerlinks, AV; et al. High risk of relapsed disease in patients with NK/T-cell chronic active Epstein-Barr virus disease outside of Asia. Blood Advances. 2022; 6:452-459.

Dewire, M; Lazow, M; Campagne, O; Leach, J; Fuller, C; Senthil Kumar, S; Stanek, J; De Blank, P; Hummel, TR; Pillay-Smiley, N; et al. Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium report. Neuro-Oncology Advances. 2022; 4.

Dimitrova, D; Nademi, Z; Maccari, ME; Ehl, S; Uzel, G; Tomoda, T; Okano, T; Imai, K; Carpenter, B; Ip, W; et al. International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndrome. Journal of Allergy and Clinical Immunology. 2022; 149:410-421.e7.

Dong, M; Emoto, C; Fukuda, T; Arnold, DE; Mehta, PA; Marsh, RA; Vinks, AA. Model-informed precision dosing for alemtuzumab in paediatric and young adult patients undergoing allogeneic haematopoietic cell transplantation. British Journal of Clinical Pharmacology. 2022; 88:248-259.

Dudek, M; Kabala, C; Labaz, B; Krupski, M. Application of Infrared Spectroscopy Techniques for Identification of Ancient Vegetation and Soil Change on Loess Areas. Land. 2022; 11.

Durkee-Shock, J; Zhang, A; Liang, H; Wright, H; Magnusson, J; Garabedian, E; Marsh, RA; Sullivan, KE; Keller, MD; Puck, J; et al. Morbidity, Mortality, and Therapeutics in Combined Immunodeficiency: Data From the USIDNET Registry. Journal of Allergy and Clinical Immunology: In Practice. 2022; 10:1334-1341.e6.

Edwards, A; Teusink-Cross, A; Martin, LJ; Prows, CA; Mehta, PA; Ramsey, LB. Influence of CYP2D6 metabolizer status on ondansetron efficacy in pediatric patients undergoing hematopoietic stem cell transplantation: A case series. Clinical and Translational Science. 2022; 15:610-618.

Elgarten, CW; Tanes, C; Lee, JJ; Danziger-Isakov, LA; Grimley, MS; Green, M; Michaels, MG; Barnum, JL; Ardura, MI; Auletta, JJ; et al. Early stool microbiome and metabolome signatures in pediatric patients undergoing allogeneic hematopoietic cell transplantation. Pediatric Blood and Cancer. 2022; 69.

Fabrizio, VA; Phillips, CL; Lane, A; Baggott, C; Prabhu, S; Egeler, E; Mavroukakis, S; Pacenta, H; Rossoff, J; Stefanski, HE; et al. Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report. Blood Advances. 2022; 6:600-610.

Fitch, T; Bleesing, J; Marsh, RA; Chandra, S. Reduced Intensity Conditioning Allogeneic Transplant for SCID Associated with Cartilage Hair Hypoplasia. Journal of Clinical Immunology. 2022.

Furutani, E; Liu, S; Galvin, A; Steltz, S; Malsch, MM; Loveless, SK; Mount, L; Larson, JH; Queenan, K; Bertuch, AA; et al. Hematologic complications with age in Shwachman-Diamond syndrome. Blood Advances. 2022; 6:297-306.

Galletta, TJ; Loveless, SK; Malsch, MM; Shimamura, A; Myers, KC. Coronavirus disease 2019 and vaccination in patients with Shwachman-Diamond syndrome. Pediatric Blood and Cancer. 2022; 69.

Gardner, JC; Courter, JD; Dandoy, CE; Davies, SM; Teusink-Cross, A. Safety and Efficacy of Prophylactic Levofloxacin in Pediatric and Adult Hematopoietic Stem Cell Transplantation Patients. Transplantation and cellular therapy. 2022; 28:167.e1-167.e5.

Gecili, E; Sivaganesan, S; Asar, O; Clancy, JP; Ziady, A; Szczesniak, RD. Bayesian regularization for a nonstationary Gaussian linear mixed effects model. Statistics in Medicine. 2022; 41:681-697.

Gracia-Maldonado, G; Clark, J; Burwinkel, M; Greenslade, B; Wunderlich, M; Salomonis, N; Leone, D; Gatti, E; Pierre, P; Kumar, AR; et al. LAMP-5 is an essential inflammatory-signaling regulator and novel immunotherapy target for mixed lineage leukemia-rearranged acute leukemia. Haematologica. 2022; 107:803-815.

Greene, AN; Nguyen, ET; Paranjpe, A; Lane, A; Privette Vinnedge, LM; Solomon, MB. In silico gene expression and pathway analysis of DEK in the human brain across the lifespan. European Journal of Neuroscience. 2022; 56:4720-4743.

Hayes, D; Melicoff-Portillo, E; Ziady, AG. Selection of lung transplant candidates: A pediatric perspective on the International Society for Heart and Lung Transplantation consensus document. Journal of Heart Transplantation. 2022; 41:998-999.

Hayes, D; Shukla, RK; Cheng, Y; Gecili, E; Merling, MR; Szczesniak, RD; Ziady, AG; Woods, JC; Hall-Stoodley, L; Liyanage, NP M; et al. Tissue-localized immune responses in people with cystic fibrosis and respiratory nontuberculous mycobacteria infection. JCI insight. 2022; 7.

Howell, J; Dandoy, C; Wright, JM; Chow, L; El-Sheikh, A; Dole, M; Vatner, RE; Kamian, K. Extraneural recurrence of an intracranial nongerminomatous germ cell tumor to cervical lymph nodes in a pediatric patient: Case report. Cancer reports.. 2022; 5.

Jodele, S; Dandoy, CE; Sabulski, A; Koo, J; Lane, A; Myers, KC; Wallace, G; Chima, RS; Teusink-Cross, A; Hirsch, R; et al. Transplantation-Associated Thrombotic Microangiopathy Risk Stratification: Is There a Window of Opportunity to Improve Outcomes?. Transplantation and cellular therapy. 2022; 28:392.e1-392.e9.

Jumanazarov, D; Koo, J; Poulsen, HF; Olsen, UL; Iovea, M. Significance of the spectral correction of photon counting detector response in material classification from spectral x-ray CT. Journal of Medical Imaging. 2022; 9.

Kapadia, M; Lehmann, L; Auletta, J; Beatty, L; Bhatt, N; Blacken, R; Demmel, K; Dodd, T; Desmond, C; Fitch, T; et al. Quality Improvement in Hematopoietic Stem Cell Transplant and Cellular Therapy: Using the Model for Improvement to impact Outcomes. Transplantation and cellular therapy. 2022; 28:233-241.

Kemps, PG; Picarsic, J; Durham, BH; Hélias-Rodzewicz, Z; Hiemcke-Jiwa, L; van den Bos, C; van de Wetering, MD; van Noesel, CJ M; van Laar, JA M; Verdijk, RM; et al. ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition. Blood. 2022; 139:256-280.

Khalil, N; Kasten, JL; Marsh, RA; Danziger-Isakov, L. Multifocal Trichosporon asahii Infection in a Patient With Chronic Granulomatous Disease. Journal of the Pediatric Infectious Diseases Society. 2022.

Khandelwal, P; Chaturvedi, V; Owsley, E; Efebera, YA; Choe, H; Bostic, M; Kumchala, P; Rajgolikar, G; Ranganathan, P; Garzon, R; et al. Prospective two center study of CD38 bright CD8+ effector memory T-cells as a predictor of acute GVHD. Transplantation Reports. 2022; 7.

Koo, J; Auletta, JJ; Hartley, DM; Huber, J; Jaglowski, S; Kapadia, M; Kusnier, K; Lehmann, L; Maakaron, J; Myers, KC; et al. Secondary Impact of the Coronavirus Disease 19 Pandemic on Patients and the Cellular Therapy Healthcare Ecosystem. Transplantation and cellular therapy. 2022.

Koo, J; Kim, M; Shin, KJ; Seo, JH. Non-Palladium-Catalyzed Approach to the Synthesis of (E)-3-(1,3-Diarylallylidene)Oxindoles. Molecules. 2022; 27.

Koo, J; McNelis, K; Mukthapuram, S; Rao, K; Caruso, CG; Rent, S. Roadmap to Success: Interactive Timeline With Resources for Fellowship Scholarly Activity. Journal of graduate medical education. 2022; 14:338-340.

Kumar, D; Prince, C; Bennett, CM; Briones, M; Lucas, L; Russell, A; Patel, K; Chonat, S; Graciaa, S; Edington, H; et al. T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome. Blood. 2022; 139:369-383.

Landspersky, T; Saçma, M; Rivière, J; Hecker, JS; Hettler, F; Hameister, E; Brandstetter, K; Istvánffy, R; Romero Marquez, S; Ludwig, R; et al. Autophagy in mesenchymal progenitors protects mice against bone marrow failure after severe intermittent stress. Blood. 2022; 139:690-703.

Lane, A. Conditional information and inference in response-adaptive allocation designs. Statistics in Medicine. 2022; 41:390-406.

Lazow, MA; Fuller, C; Dewire, M; Lane, A; Bandopadhayay, P; Bartels, U; Bouffet, E; Cheng, S; Cohen, KJ; Cooney, TM; et al. Accuracy of central neuro-imaging review of DIPG compared with histopathology in the International DIPG Registry. Neuro-Oncology. 2022; 24:821-833.

Lazow, MA; Nievelstein, MT; Lane, A; Bandopadhayhay, P; DeWire-Schottmiller, M; Fouladi, M; Glod, JW; Greiner, RJ; Hoffman, LM; Hummel, TR; et al. Volumetric endpoints in diffuse intrinsic pontine glioma: comparison to cross-sectional measures and outcome correlations in the International DIPG/DMG Registry. Neuro-Oncology. 2022; 24:1598-1608.

Marsh, RA. Does shining a spotlight on XIAP deficiency bring the role of allogeneic HCT into better focus?. Journal of Allergy and Clinical Immunology. 2022; 150:297-298.

Marsh, RA; Hebert, K; Kim, S; Dvorak, CC; Aquino, VM; Baker, KS; Chellapandian, D; Dávila Saldaña, B; Duncan, CN; Eckrich, MJ; et al. Comparison of hematopoietic cell transplant conditioning regimens for hemophagocytic lymphohistiocytosis disorders. Journal of Allergy and Clinical Immunology. 2022; 149:1097-1104.e2.

Meri, S; Bunjes, D; Cofiell, R; Jodele, S. The Role of Complement in HSCT-TMA: Basic Science to Clinical Practice. Advances in Therapy. 2022; 39:3896-3915.

Merjaneh, N; Young, J; Mangoli, A; Olsen, M; Setty, B; Lane, A; Nagarajan, R; Pressey, JG; Turpin, B. Chemotherapy-induced thrombocytopenia in Ewing sarcoma: Implications and potential for romiplostim supportive care. Pediatric Blood and Cancer. 2022; 69.

Milgrom, SA; Koo, J; Foreman, N; Liu, AK; Campbell, K; Dorris, K; Green, AL; Dahl, N; Donson, AM; Vibhakar, R; et al. Radiation Therapy for Young Children Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant for Primary Brain Tumors. Advances in Radiation Oncology. 2022; 7.

Milne, P; Bomken, S; Slater, O; Kumar, AR; Nelson, AS; Roy, S; Velazquez, J; Mankad, K; Nicholson, J; Yeomanson, D; et al. Lineage-switching of the cellular distribution of BRAFV600E in multisystem Langerhans cell histiocytosis. Blood Advances. 2022.

Mizuno, K; Dandoy, CE; Teusink-Cross, A; Davies, SM; Vinks, AA; Jodele, S. Eculizumab precision-dosing algorithm for thrombotic microangiopathy in children and young adults undergoing HSCT. Blood Advances. 2022; 6:1454-1463.

Morrison, CF; Drake, S; Basile, NL; Horn, MJ; Lambert, J; Myers, KC; Pai, AL H. Symptoms of Survivors of Pediatric Hematopoietic Stem Cell Transplant by Age, Sex, and Transplant Type. 2022; 39:277-289.

Odegard, EA; Meeds, HL; Kleiboeker, SB; Ziady, A; Sabulski, A; Jodele, S; Seif, AE; Davies, SM; Laskin, BL; Blackard, JT. Optimized amplification of BK polyomavirus in urine. Journal of Virological Methods. 2022; 299.

Odegard, EA; Meeds, HL; Kleiboeker, SB; Ziady, A; Sabulski, A; Jodele, S; Seif, AE; Davies, SM; Laskin, BL; Blackard, JT. BK Polyomavirus Subtypes II and IV in Hematopoietic Cell Transplant Recipients. Microbiology Resource Announcements. 2022; 11.

Oh, JH; Han, YE; Bao, YR; Kang, CW; Koo, J; Ku, CR; Cho, YH; Lee, EJ. Olfactory marker protein regulation of glucagon secretion in hyperglycemia. Korean Journal of Biochemistry. 2022; 54:1502-1510.

Padem, N; Wright, H; Fuleihan, R; Garabedian, E; Suez, D; Cunningham-Rundles, C; Marsh, RA; Khojah, A. Rheumatologic diseases in patients with inborn errors of immunity in the USIDNET registry. Clinical Rheumatology. 2022; 41:2197-2203.

Park, S; Koo, J; Kim, B; Pushparaj, K; Malaisamy, A; Liu, W; Balasubramanian, B. Evaluation of the Safety and Ochratoxin A Degradation Capacity of Pediococcus pentosaceus as a Dietary Probiotic with Molecular Docking Approach and Pharmacokinetic Toxicity Assessment. International Journal of Molecular Sciences. 2022; 23.

Powell, AW; Urbina, EM; Madueme, P; Rotz, S; Chin, C; Taylor, MD; Mays, WA; Davies, SM; Lane, A; Berger, S; et al. Abnormal Maximal and Submaximal Cardiopulmonary Exercise Capacity in Pediatric Stem Cell Transplant Recipients Despite Normal Standard Echocardiographic Parameters: A Pilot Study. Transplantation and cellular therapy. 2022; 28:263.e1-263.e5.

Power-Hays, A; Dandoy, CE; Lorts, A; Perentesis, JP; Unaka, N; Ware, RE; McGann, PT. US News & World Report and quality metrics: Inclusion of sickle cell disease is a matter of equity. Pediatric Blood and Cancer. 2022; 69.

Qayed, M; Watkins, B; Gillespie, S; Bratrude, B; Betz, K; Choi, SW; Davis, J; Duncan, C; Giller, R; Grimley, M; et al. Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation. Blood Advances. 2022; 6:746-749.

Rubinstein, JD; Jodele, S; Heyenbruch, D; Wilhelm, J; Thomas, S; Lutzko, C; Zhu, X; Leemhuis, T; Cancelas, JA; Keller, M; et al. Off-the-Shelf Third-Party Virus-Specific T Cell Therapy to Treat JC Polyomavirus Infection in Hematopoietic Stem Cell Transplantation Recipients. Transplantation and cellular therapy. 2022; 28:116.e1-116.e7.

Rubinstein, JD; Lutzko, C; Leemhuis, T; Zhu, X; Pham, G; Ray, L; Thomas, S; Dourson, C; Wilhelm, J; Lane, A; et al. Scheduled administration of virus-specific T cells for viral prophylaxis after pediatric allogeneic stem cell transplant. Blood Advances. 2022; 6:2897-2907.

Sabulski, A; Abdullah, S; Luebbering, N; Aunins, B; Castillo, C; Lake, K; Duell, A; Strecker, L; Giordullo, L; Broomhead, W; et al. Circulating endothelial cells and the study of vascular injury in children undergoing hematopoietic stem cell transplant. Haematologica. 2022.

Sabulski, A; Arcuri, G; Szabo, S; Care, MM; Dandoy, CE; Davies, SM; Jodele, S. Cerebral vascular injury in transplant-associated thrombotic microangiopathy. Blood Advances. 2022; 6:4310-4319.

Sabulski, A; Grier, DD; Myers, KC; Davies, SM; Rubinstein, JD. Acute myeloid leukemia in SRP54-mutated congenital neutropenia. 2022; 3:521-525.

Sabulski, A; Jodele, S. What complements complement in transplant-associated thrombotic microangiopathy?. British Journal of Haematology. 2022.

Sabulski, A; Nehus, EJ; Jodele, S; Ricci, K. Diagnostic Considerations in H1N1 Influenza-induced Thrombotic Microangiopathy. Journal of Pediatric Hematology/Oncology. 2022; 44:e237-e240.

Schmitt, EG; Toth, KA; Risma, SI; Kolicheski, A; Saucier, N; Feliciano Berríos, RJ; Greenberg, ZJ; Leiding, JW; Bleesing, JJ; Thatayatikom, A; et al. A human STAT3 gain-of-function variant confers T cell dysregulation without predominant Treg dysfunction in mice. JCI insight. 2022.

Shah, NC; Bhoopatiraju, S; Abraham, A; Anderson, E; Andreansky, M; Bhatia, M; Chaudhury, S; Cuvelier, GD E; Godder, K; Grimley, M; et al. Granulocyte Colony-Stimulating Factor Is Safe and Well Tolerated following Allogeneic Transplantation in Patients with Sickle Cell Disease. Transplantation and cellular therapy. 2022; 28:174.e1-174.e5.

Singh, A; Dandoy, CE; Chen, M; Kim, S; Mulroney, CM; Kharfan-Dabaja, MA; Ganguly, S; Maziarz, RT; Kanakry, CG; Kanakry, JA; et al. Post-Transplantation Cyclophosphamide Is Associated with an Increase in Non-Cytomegalovirus Herpesvirus Infections in Patients with Acute Leukemia and Myelodysplastic Syndrome. Transplantation and cellular therapy. 2022; 28:48.e1-48.e10.

Smart, LR; Ambrose, EE; Balyorugulu, G; Songoro, P; Shabani, I; Komba, P; Charles, M; Howard, TA; McElhinney, KE; O'Hara, SM; et al. Stroke Prevention with Hydroxyurea Enabled through Research and Education (SPHERE): a Phase 2 primary stroke prevention trial in sub-Saharan Africa. Acta Haematologica. 2022.

Smith, KL; Dai, D; Modi, BP; Sara, R; Garabedian, E; Marsh, RA; Puck, J; Secord, E; Sullivan, KE; Turvey, SE; et al. Inborn Errors of Immunity Associated With Type 2 Inflammation in the USIDNET Registry. Frontiers in Immunology. 2022; 13.

Swauger, S; Sabulski, A; Hornung, L; Wasserman, H; Myers, KC; Howell, JC. Bone Health Outcomes at 1 Year after Hematopoietic Stem Cell Transplantation in a Heterogeneous Pediatric Population. Transplantation and cellular therapy. 2022; 28:44.e1-44.e6.

Tang, Y; Xu, Q; Luo, H; Yan, X; Wang, G; Hu, L; Jin, J; Witte, DP; Marsh, RA; Huang, L; et al. Excessive IL-10 and IL-18 trigger hemophagocytic lymphohistiocytosis-like hyperinflammation and enhanced myelopoiesis. Journal of Allergy and Clinical Immunology. 2022.

Tomomasa, D; Booth, C; Bleesing, JJ; Isoda, T; Kobayashi, C; Koike, K; Taketani, T; Sawada, A; Tamura, A; Marsh, RA; et al. Preemptive hematopoietic cell transplantation for asymptomatic patients with X-linked lymphoproliferative syndrome type 1. Clinical Immunology. 2022; 237.

Vasu, S; Bostic, M; Zhao, Q; Sharma, N; Puto, M; Knight, S; Scott, D; Guzman, R; Kromer, M; Tackett, K; et al. Acute GVHD, BK virus hemorrhagic cystitis and age are risk factors for transplant-associated thrombotic microangiopathy in adults. Blood Advances. 2022; 6:1342-1349.

Wang, YZ M; Gloude, NJ; Davies, SM; Lucky, AW; Nelson, AS. Reply to: Comment on: Hematopoietic stem cell transplant for erythropoietic porphyrias in pediatric patients. Pediatric Blood and Cancer. 2022; 69.

Wang, YZ M; Teusink-Cross, A; Elborai, Y; Krupski, MC; Nelson, AS; Grimley, MS; Flannery, A; Mehta, PA; Bleesing, JJ; Chandra, S; et al. Ruxolitinib for the Treatment of Chronic GVHD and Overlap Syndrome in Children and Young Adults. Transplantation. 2022; 106:412-419.

Zoref-Lorenz, A; Murakami, J; Hofstetter, L; Iyer, S; Alotaibi, AS; Mohamed, SF; Miller, PG; Guber, E; Weinstein, S; Yacobovich, J; et al. An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosis. Blood. 2022; 139:1098-1110.